Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →A patent landscape review of free flow prevention in infusion pump systems: leading assignees, filing trends since 2015, IPC technology composition and the most-cited prior art, drawn from 222 published records.
Top-5 share = the 5 largest assignees ÷ all 222 records in scope (CR5), not the ranked leaders only.
Free flow — the uncontrolled gravity-driven delivery of fluid through IV tubing when it is disconnected from an infusion pump or when a door or cassette fails to seat — is a patient-safety failure mode that regulators and manufacturers have spent three decades trying to design out. This landscape covers 222 published records filed between 2015 and 2026 that combine infusion pump or intravenous pump terms with free-flow prevention language and claim mechanisms such as clamps, interlocks and mechanical stops, restricted to the A61M5 subclass covering devices for introducing media into the body.
The scope captures both the mechanical hardware that physically occludes tubing and the surrounding electronic and software claims that detect or manage a free-flow event, giving a view across the full stack of prevention strategies rather than one component alone.
Publication lags filing by roughly 18 months, so the most recent years in the trend below are understated relative to true filing activity.
Annual filings run from 3 records in 2017 to a peak of 4 in 2019, with 2026 showing 0 as a partial year. Across the period there is no sustained upward trend — this looks like a mature mechanical-safety category with periodic refiling rather than a technology in an active growth phase.
Beyond the A61M base class that defines the search, positive-displacement pump claims (F04B, 15.3% of the 222 records) and valve/tap claims (F16K, 9.5%) are the next densest branches, followed by medicine containers (A61J, 8.1%) and rotary-piston pumps (F04C, 4.5%). Data-processing classes (G06F and G06Q) each cover only 2.3% of records, marking software-driven detection and control as the thinnest represented branch relative to the mechanical categories.
Shares are the percentage of the 222 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about free flow prevention in infusion pump systems patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaA free flow prevention system for preventing free flow of fluid through IV tubing when the tubing is disconnected from an infusion pump. A flexible clamp is provided having a pair of clamping arms, which define a variable width slot for receiving the IV tubing. The IV tubing may be moved along the slot between a first position wherein the width of the slot is sufficient to permit the clamp to be positioned longitudinally along the IV tubing, and a second position wherein the width of the slot is normally less than the width of the slot at the first position, closing the tubing when it is not seated in the pump.Filed by Graseby Medical Limited, published 1991 — one of the earliest mechanical clamp approaches in this dataset and a frequent citation anchor for later occluder designs.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US5816779A | Disposable fluid infusion pumping cassette having an interrelated flow control and pressure monitoring arrang… | 315 |
| 2 | US5601420A | Interlock, latching, and retaining mechanism for an infusion pump | 218 |
| 3 | US20020165503A1 | Medical instrument flow stop interface | 196 |
| 4 | US6659976B2 | Feeding set adaptor | 154 |
| 5 | US5704584A | Pinch clip occluder for infusion sets | 143 |
| 6 | US6852094B2 | Infusion set adaptor | 139 |
| 7 | US5017192A | Free flow prevention system for infusion pump | 136 |
| 8 | US5453098A | Two step IV fluid flow stop | 128 |
| 9 | US6629955B2 | Medical instrument flow stop interface | 110 |
| 10 | US5401256A | Flexible clamp for use in IV tubing set | 100 |
Citation counts inside a searched corpus favour older records — read them as a signal of influence on later filings, not as a measure of current commercial importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three patterns stand out once the records are ranked by assignee, year and IPC class.
With the leading assignee alone holding 45 records and the top five combined controlling 46.4% of the 222 records in scope, new entrants are filing into a space where the dominant mechanical clamp and interlock approaches are already well covered by a small number of established infusion-device makers.
Annual filings never exceed single digits across the period, with the highest count only 4 records in 2019. That pattern is consistent with periodic design-around refiling on an established safety mechanism rather than a technology attracting fresh investment.
Mechanical occlusion and valve claims (F04B, F16K, A61J, F04C) account for meaningfully larger shares of the 222 records than the data-processing classes G06F and G06Q, each at just 2.3%. Claims around software-based flow anomaly detection and connected-pump alerting sit on far less prior art than the physical clamp mechanisms.
The United States (54 records) and the European Patent Office (44) are the leading receiving offices, with Canada, Australia, WIPO and Japan each in double digits behind them. A design-around strategy needs to clear both US and European prior art, not just one jurisdiction.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to free flow prevention in infusion pump systems patent landscape, with the prior art for and against each one.
The counts and rankings above show where claim density sits today. Deciding where to file next means testing a specific mechanism or claim idea against that density directly.
Run the mechanism you are considering against the records held by the top assignees to see how close your claim language sits to existing occluder and interlock patents before drafting.
Explore in Patsnap Eureka →Data-processing classes cover a small share of this dataset. Test whether a flow-anomaly detection or connected-alerting claim is genuinely open or simply unindexed under these IPC codes.
Explore in Patsnap Eureka →In this dataset, a free flow prevention patent is a filing under the A61M5 subclass (devices for introducing media into the body) that combines infusion or intravenous pump terminology with free-flow, uncontrolled-infusion or runaway-flow language, and claims a prevention mechanism such as a clamp, interlock or mechanical stop. That typically means a physical device — a spring-loaded clamp, a door interlock, or a valve — that closes IV tubing automatically when it is removed from the pump or when the pump housing is opened. Some records also extend into electronic detection of a free-flow condition, though this is a smaller share of the field. The scope in this landscape covers 222 published records filed between 2015 and 2026.
The assignee ranking behind this landscape covers 76 companies counted by patent family, with the leading assignee holding 45 of the 222 records. Filing is concentrated: the top five assignees combined hold 46.4% of all records, and the top ten hold 68.0%. That means well over half the field's patent activity sits with a small group of established infusion-device manufacturers, leaving a long tail of single- or few-filing entrants behind them.
The filing trend does not show a growth curve. Annual counts run from 3 records in 2017 to a peak of just 4 in 2019, with no year in the dataset showing a clear surge, and 2026 is a partial year showing 0 so far. Because publication typically lags filing by around 18 months, the last one to two years in any such trend will always look artificially low. Overall the pattern reads as a mature mechanical-safety category with steady, low-volume refiling rather than an emerging or fast-growing one.
Outside the A61M base class that defines the whole search, the densest adjacent classes are F04B (positive-displacement pumps) at 15.3% of the 222 records and F16K (valves and taps) at 9.5%. A61J (containers for medicine) covers 8.1%, and F04C (rotary-piston pumps) covers 4.5%. Because a single record can carry several IPC classes, these shares add up to more than 100% of the record total — that overlap is expected and reflects how mechanical pump, valve and tubing claims are frequently bundled together in the same filing.
The clearest gap sits in software and data-processing classes: G06F and G06Q each cover only 2.3% of the 222 records, far below the mechanical clamp, valve and pump classes. That suggests claims built around software-based flow-anomaly detection, connected-pump alerting, or algorithmic occlusion sensing sit on much less prior art than physical clamp mechanisms do. Anyone drafting in this space should still verify that gap directly against the leading assignees' portfolios, since a thin IPC share can also reflect indexing gaps rather than genuine open space.
Go past this page: query the whole free flow prevention in infusion pump systems patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Help us improve
Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.
This page